Apellis Pharmaceuticals Inc APLS Investor Alert Robbins LLP Reminds Shareholders of Class Action Against Apellis Pharmaceuticals Inc

SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons and entities who purchased or otherwise acquires shares of Apellis common stock between January 28, 2021 and July 28, 2023. Apellis…Read More